AUO-Studienaktivit äten in der Uro-Onkologie
Aktuelle Urol. 2024 Apr;55(2):103-105. doi: 10.1055/a-2270-3784. Epub 2024 Mar 27.NO ABSTRACTPMID:38537658 | DOI:10.1055/a-2270-3784 (Source: Aktuelle Urologie)
Source: Aktuelle Urologie - March 27, 2024 Category: Urology & Nephrology Source Type: research
Molecular testing of prostate cancer: timing, methods and consequences
Aktuelle Urol. 2024 Apr;55(2):123-133. doi: 10.1055/a-2266-3607. Epub 2024 Mar 27.ABSTRACTMetastatic prostate cancer is a heterogeneous disease. To date, however, treatment decisions are often based on the extent and symptom burden of the tumour, concomitant diseases, and the patient's wishes. Molecular pathology aspects are rarely taken into account. Declining costs and the increasing use of next-generation sequencing (NGS) have led to an increase in molecular testing and a better understanding of the significance of molecular alterations for the development and spread of prostate cancer. More consistent germline testing ...
Source: Aktuelle Urologie - March 27, 2024 Category: Urology & Nephrology Authors: Gunhild von Amsberg Finn-Ole Paulsen Source Type: research
Is there an indication for local treatment in metastasised hormone-sensitive prostate cancer?
Aktuelle Urol. 2024 Apr;55(2):134-138. doi: 10.1055/a-2175-3159. Epub 2024 Mar 27.ABSTRACTIn case of newly diagnosed metastasised hormone-sensitive prostate cancer, there are two indications for local treatment: to reduce or avoid local symptoms thus improving quality of life and prolonging survival in a subset of patients. Local treatment must be seen in a multimodal treatment approach and is not a replacement of systemic treatment. In the following review, we highlight the current literature for the different local treatment options, radiotherapy and radical prostatectomy, and try to give indications for which option sho...
Source: Aktuelle Urologie - March 27, 2024 Category: Urology & Nephrology Authors: Constantin Rieger David Pfister Jonathan Hollmann Alexandros Papachristofilou Source Type: research
Sequenztherapie des kastrationsresistenten Prostatakarzinoms: Evidenzbasierte klinische Algorithmen
Aktuelle Urol. 2024 Apr;55(2):161-173. doi: 10.1055/a-2201-6485. Epub 2024 Mar 27.NO ABSTRACTPMID:38537661 | DOI:10.1055/a-2201-6485 (Source: Aktuelle Urologie)
Source: Aktuelle Urologie - March 27, 2024 Category: Urology & Nephrology Authors: Tobias Peres Aurelius Omlin Source Type: research
Das metastasierte Prostatakarzinom bleibt weiterhin eine therapeutische Herausforderung
Aktuelle Urol. 2024 Apr;55(2):81. doi: 10.1055/a-2175-3573. Epub 2024 Mar 27.NO ABSTRACTPMID:38537650 | DOI:10.1055/a-2175-3573 (Source: Aktuelle Urologie)
Source: Aktuelle Urologie - March 27, 2024 Category: Urology & Nephrology Authors: Axel Heidenreich Source Type: research
Prostatakarzinom-Staging: T-Stadium mit oder ohne Einbeziehung der Bildgebung?
Aktuelle Urol. 2024 Apr;55(2):90. doi: 10.1055/a-2188-9541. Epub 2024 Mar 27.NO ABSTRACTPMID:38537651 | DOI:10.1055/a-2188-9541 (Source: Aktuelle Urologie)
Source: Aktuelle Urologie - March 27, 2024 Category: Urology & Nephrology Source Type: research
Kommentar zu: Prostatakarzinom-Staging: T-Stadium mit oder ohne Einbeziehung der Bildgebung?
Aktuelle Urol. 2024 Apr;55(2):90-92. doi: 10.1055/a-2220-2433. Epub 2024 Mar 27.NO ABSTRACTPMID:38537652 | DOI:10.1055/a-2220-2433 (Source: Aktuelle Urologie)
Source: Aktuelle Urologie - March 27, 2024 Category: Urology & Nephrology Source Type: research
Gesundheitsbezogene Lebensqualit ät nach radikaler Zystektomie
Aktuelle Urol. 2024 Apr;55(2):92-94. doi: 10.1055/a-2082-3877. Epub 2024 Mar 27.NO ABSTRACTPMID:38537653 | DOI:10.1055/a-2082-3877 (Source: Aktuelle Urologie)
Source: Aktuelle Urologie - March 27, 2024 Category: Urology & Nephrology Source Type: research
Kommentar zu: Gesundheitsbezogene Lebensqualit ät nach radikaler Zystektomie
Aktuelle Urol. 2024 Apr;55(2):94-96. doi: 10.1055/a-2223-2793. Epub 2024 Mar 27.NO ABSTRACTPMID:38537654 | DOI:10.1055/a-2223-2793 (Source: Aktuelle Urologie)
Source: Aktuelle Urologie - March 27, 2024 Category: Urology & Nephrology Source Type: research
Rucaparib beim kastrationsresistenten, metastasierten Prostatakarzinom
Aktuelle Urol. 2024 Apr;55(2):96-98. doi: 10.1055/a-2189-0029. Epub 2024 Mar 27.NO ABSTRACTPMID:38537655 | DOI:10.1055/a-2189-0029 (Source: Aktuelle Urologie)
Source: Aktuelle Urologie - March 27, 2024 Category: Urology & Nephrology Source Type: research
Kommentar zu: Rucaparib beim kastrationsresistenten, metastasierten Prostatakarzinom
Aktuelle Urol. 2024 Apr;55(2):98. doi: 10.1055/a-2241-6635. Epub 2024 Mar 27.NO ABSTRACTPMID:38537656 | DOI:10.1055/a-2241-6635 (Source: Aktuelle Urologie)
Source: Aktuelle Urologie - March 27, 2024 Category: Urology & Nephrology Source Type: research
Einsatz von TAR-200 und Cetrelimab bei Patienten mit NMIBC nach BCG-Therapie, die keine Zystektomie erhalten
Aktuelle Urol. 2024 Apr;55(2):100-102. doi: 10.1055/a-2175-3560. Epub 2024 Mar 27.NO ABSTRACTPMID:38537657 | DOI:10.1055/a-2175-3560 (Source: Aktuelle Urologie)
Source: Aktuelle Urologie - March 27, 2024 Category: Urology & Nephrology Source Type: research
AUO-Studienaktivit äten in der Uro-Onkologie
Aktuelle Urol. 2024 Apr;55(2):103-105. doi: 10.1055/a-2270-3784. Epub 2024 Mar 27.NO ABSTRACTPMID:38537658 | DOI:10.1055/a-2270-3784 (Source: Aktuelle Urologie)
Source: Aktuelle Urologie - March 27, 2024 Category: Urology & Nephrology Source Type: research
Molecular testing of prostate cancer: timing, methods and consequences
Aktuelle Urol. 2024 Apr;55(2):123-133. doi: 10.1055/a-2266-3607. Epub 2024 Mar 27.ABSTRACTMetastatic prostate cancer is a heterogeneous disease. To date, however, treatment decisions are often based on the extent and symptom burden of the tumour, concomitant diseases, and the patient's wishes. Molecular pathology aspects are rarely taken into account. Declining costs and the increasing use of next-generation sequencing (NGS) have led to an increase in molecular testing and a better understanding of the significance of molecular alterations for the development and spread of prostate cancer. More consistent germline testing ...
Source: Aktuelle Urologie - March 27, 2024 Category: Urology & Nephrology Authors: Gunhild von Amsberg Finn-Ole Paulsen Source Type: research
Is there an indication for local treatment in metastasised hormone-sensitive prostate cancer?
Aktuelle Urol. 2024 Apr;55(2):134-138. doi: 10.1055/a-2175-3159. Epub 2024 Mar 27.ABSTRACTIn case of newly diagnosed metastasised hormone-sensitive prostate cancer, there are two indications for local treatment: to reduce or avoid local symptoms thus improving quality of life and prolonging survival in a subset of patients. Local treatment must be seen in a multimodal treatment approach and is not a replacement of systemic treatment. In the following review, we highlight the current literature for the different local treatment options, radiotherapy and radical prostatectomy, and try to give indications for which option sho...
Source: Aktuelle Urologie - March 27, 2024 Category: Urology & Nephrology Authors: Constantin Rieger David Pfister Jonathan Hollmann Alexandros Papachristofilou Source Type: research
